首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Calidad de Vida en Mujeres Mexicanas con Cancer de Mama en Diferentes Etapas Clinicas y su Asociacion con Caracteristicas Socio-Demograficas, Estados Co-Morbidos y Caracteristicas del Proceso de Atencion en el Instituto Mexicano del Seguro Social
【24h】

Calidad de Vida en Mujeres Mexicanas con Cancer de Mama en Diferentes Etapas Clinicas y su Asociacion con Caracteristicas Socio-Demograficas, Estados Co-Morbidos y Caracteristicas del Proceso de Atencion en el Instituto Mexicano del Seguro Social

机译:墨西哥妇女的生活质量与胰腺癌妈妈在不同阶段Clinicas及其与Caracteristicas协会Socio-Demograficas,州Co-Morbidos注意在进程Caracteristicas墨西哥社会保险研究所

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Introduction: Quality of Life is the most studied PRO (patient reported outcome) in cancer patients. With early diagnosis and better treatments in breast cancer, this entity has been transformed in a chronic disease with longer survival. The joint effects of diseases and treatment on quality of life are each day more important to consider in survival patients. Objective: To evaluate Quality of Life, Socioeco-nomic factors, co-morbidities, and the attendance process impact on quality of life in breast cancer women with different clinical stages attending at the Instituto Mexicano del Seguro Social using the EORCT QLQ-C30 Results: The scores of EORTC QLQ-C30 (v3) were: Global health status / QoL: 73.47 (±20.81), physical functioning 76.98 (±20.85), role functioning 76.60 (±27.57), emotional functioning 64.53 (±26.81), cognitive functioning 74.47 (±26.02), social functioning 84.96 (±23.20), fatigue 31.94 (±25.45), nausea and vomiting 19.49 (±26.93), pain 28.95 (±27.27), dyspnea 15.29 (±24.62), insomnia 35.13 (±32.10), appetite lost 18.04 (±28.75), 18.04 (±28.75), constipation 19.20 (±32.11), diarrhea 12.9(±24.25), financial difficulties 40.57 (±37.26). The scores with EORTC QLQ-BR23 were: body image 74.84 (±31.69), sexual functioningl3.73 (±22.55), sexual enjoyment 32.86 (±36.17), future perspectives 51.69 (±38.00), systemic therapy side effects 30.82 (±20.71), breast symp-toms22.85 (±23.49), arm symptoms 27.53 (±24.75), upsert by hair loss 43.80 (±44.01). Conclusions: Clinical stage in breast cancer is associated with differences in the scores from fatigue, nausea and vomiting and financial difficulties according to the evolution of the disease and the physical detriment associated. Socio-demographic features were related role functioning, fatigue and pain in single women with higher scores.Palabras Claues: breast cancer, process of care, QLQ-C30, QLQ-BR23, quality of life.
机译:简介:生活质量是研究最多的职业(癌症病人报告结果)病人。在乳腺癌的治疗,这个实体改变了在一个较长的慢性疾病生存。处理每天的生活质量上患者生存的重要考虑。摘要目的:评价生活质量,Socioeco-nomic因素,疾病,考勤过程对生活质量的影响与不同的临床乳腺癌的妇女阶段参加Mexicano del研究所全民社会使用EORCT QLQ-C30结果:的分数EORTC QLQ-C30 (v3):全球健康状况/生命质量:73.47(±20.81),物理功能76.98(±20.85)、角色功能64.53(76.60±27.57),情感功能(±26 . 81),认知functioning 74个47(±),社会功能84.96(±23.20),疲劳31.94(±25.45),19.49(±26.93),恶心和呕吐失眠35.13(±32.10),食欲下跌18.04(28±4。75),18(28±75),第20 constipation 19。困难40.57(±37.26)。EORTC QLQ-BR23是:身体形象74.84(±31.69),性functioningl3.73(±22.55)、性享受32.86(±36.17),未来的观点51.69(±38.00),系统性治疗的副作用30 . 82(±20 / 71),乳房symp-toms22 85点(±23 . 49),手臂症状27.53(±24.75)、脱发43.80(±44.01)。乳腺癌与差异有关分数从疲劳、恶心和呕吐根据进化财政困难和物理损害的疾病相关联的。相关的角色功能,疲劳和疼痛单身女性得分越高。乳腺癌治疗的过程,QLQ-C30,QLQ-BR23,生活的质量。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号